335 related articles for article (PubMed ID: 15580404)
1. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy using talaporfin sodium (Laserphyrin®) for bile duct carcinoma: a preliminary clinical trial.
Nanashima A; Abo T; Nonaka T; Nonaka Y; Morisaki T; Uehara R; Ohnita K; Fukuda D; Murakami G; Tou K; Kunizaki M; Hidaka S; Tsuchiya T; Takeshita H; Nakao K; Nagayasu T
Anticancer Res; 2012 Nov; 32(11):4931-8. PubMed ID: 23155262
[TBL] [Abstract][Full Text] [Related]
4. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
[TBL] [Abstract][Full Text] [Related]
5. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy in cholangiocarcinomas.
Ortner MA
Best Pract Res Clin Gastroenterol; 2004 Feb; 18(1):147-54. PubMed ID: 15123089
[TBL] [Abstract][Full Text] [Related]
7. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.
Zoepf T; Jakobs R; Arnold JC; Apel D; Riemann JF
Am J Gastroenterol; 2005 Nov; 100(11):2426-30. PubMed ID: 16279895
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy for cholangiocarcinoma.
Berr F
Semin Liver Dis; 2004 May; 24(2):177-87. PubMed ID: 15192790
[TBL] [Abstract][Full Text] [Related]
9. Technology insight: Photodynamic therapy for cholangiocarcinoma.
Ortner MA; Dorta G
Nat Clin Pract Gastroenterol Hepatol; 2006 Aug; 3(8):459-67. PubMed ID: 16883350
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy--Long-Term Outcome of a Phase II Pilot Study.
Wagner A; Wiedmann M; Tannapfel A; Mayr C; Kiesslich T; Wolkersdörfer GW; Berr F; Hauss J; Witzigmann H
Int J Mol Sci; 2015 Nov; 16(11):26619-28. PubMed ID: 26561801
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy.
Cheon YK; Cho YD; Moon JH; Jang JY; Kim YS; Kim YS; Lee MS; Lee JS; Shim CS
Am J Gastroenterol; 2007 Oct; 102(10):2164-70. PubMed ID: 17617204
[TBL] [Abstract][Full Text] [Related]
12. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma.
Kiesslich T; Wolkersdörfer G; Neureiter D; Salmhofer H; Berr F
Photochem Photobiol Sci; 2009 Jan; 8(1):23-30. PubMed ID: 19247524
[TBL] [Abstract][Full Text] [Related]
14. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for unresectable cholangiocarcinoma: contribution of single operator cholangioscopy for targeted treatment.
Talreja JP; DeGaetani M; Sauer BG; Kahaleh M
Photochem Photobiol Sci; 2011 Jul; 10(7):1233-8. PubMed ID: 21512706
[TBL] [Abstract][Full Text] [Related]
17. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for cholangiocarcinoma: overview and new developments.
Ortner MA
Curr Opin Gastroenterol; 2009 Sep; 25(5):472-6. PubMed ID: 19550314
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L; Sotti G
Lasers Surg Med; 2007 Jun; 39(5):394-402. PubMed ID: 17565719
[TBL] [Abstract][Full Text] [Related]
20. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
